Our results suggest that TRIM21 is a crucial suppressor of hepatic glucose and lipid metabolism disorders and insulin resistance and thus may serve as a molecular target for treating type 2 diabetes mellitus. The gene discussed is TRIM21; the disease is Insulin resistance.